BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9868137)

  • 1. [Assay of serum beta 2-microglobulin in patients with malignant hematologic diseases and its clinical significance].
    Zhong M; Liu W
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):277-8. PubMed ID: 9868137
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum levels of beta 2-microglobulin in malignant hemopathies].
    López Fernández A; Cuesta B; Rocha E
    Sangre (Barc); 1985; 30(3):320-9. PubMed ID: 3898421
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical significance of correction of serum beta 2-microglobulin levels for serum creatinine in multiple myeloma.
    Scudla V; Vavrdová V; Budíková M; Indrák K
    Acta Univ Palacki Olomuc Fac Med; 1991; 131():257-64. PubMed ID: 1840347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta 2 microglobulin in serum--a "tumor marker" in malignant lymphomas?].
    Aulbert E; Steffens O
    Med Klin (Munich); 1990 Jan; 85(1):13-7. PubMed ID: 2179698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of serum beta 2-microglobulin in multiple myeloma, non-Hodgkin's malignant lymphoma and chronic lymphoid leukemia].
    Balikó Z; Tornóczky J; Pasztarak E; Tóth A; Muth L
    Orv Hetil; 1983 Jan; 124(3):131-4. PubMed ID: 6188088
    [No Abstract]   [Full Text] [Related]  

  • 6. Beta 2-microglobulin: a potentially useful marker for hematologic malignancies.
    Garewal H; Durie BG
    Ariz Med; 1981 Dec; 38(12):912-3. PubMed ID: 6174109
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical studies on serum beta2-microglobulin in multiple myeloma and other related diseases (author's transl)].
    Nishioka F; Yachi A; Wada T
    Rinsho Ketsueki; 1978 Feb; 19(2):100-6. PubMed ID: 77342
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical usefulness of serum beta2-microglobulin determination in patients with multiple myeloma].
    Kraj M; Maj S; Pogłód R; Rostkowska J
    Acta Haematol Pol; 1989; 20(2):140-51. PubMed ID: 2700533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-2-microglobulin in multiple myeloma.
    Musarurwa C; Matarira HT
    Cent Afr J Med; 2004; 50(1-2):19-20. PubMed ID: 15490720
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic and clinical studies of serum beta 2-microglobulin levels in haematological malignancies.
    Nakao Y; Matsumoto H; Miyazaki T; Watanabe S; Masaoka T; Takatsuki K; Kishihara M; Kobayashi N; Hattori M; Fujita T
    Clin Exp Immunol; 1981 Oct; 46(1):134-41. PubMed ID: 6175458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of some biochemical and immunologic factors in the management of multiple myeloma].
    Abdulkadyrov KM; Stel'mashenko LV; Bessmel'tsev SS; Lubo-Lesnichenko IF; Sel'tser AV; Rozanova OE; Gubarenko NK; Bubnova LN; Mnuskina MM; Zhuchikhina AA; Blinov MN; Gritskevich NL
    Vopr Onkol; 1998; 44(3):304-9. PubMed ID: 9695777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta 2 microglobulin].
    Clément F
    Schweiz Med Wochenschr; 1983 Jun; 113(23):838-43. PubMed ID: 6192496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta 2 microglobulin in some hematologic neoplasms].
    Rodríguez MA; Lira P; Foradori A; Grebe G
    Rev Med Chil; 1989 Jun; 116(6):538-42. PubMed ID: 2664940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The behaviour of beta-2-microglobulin in acute and chronic leukaemias.
    Schena FP; Liso V; Losuriello V; Mera S; Bonomo L
    Biomedicine; 1980 Feb; 33(1):12-5. PubMed ID: 6154490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical importance of the radioimmunological determination of the beta 2-microglobulin in acute leukemia patients].
    Vorob'ev VG; Sidnev BN
    Ter Arkh; 1990; 62(7):20-3. PubMed ID: 2251659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum beta 2 microglobulin concentration in patients with multiple myeloma].
    Mendek-Czajkowska E
    Acta Haematol Pol; 1984; 15(3-4):161-5. PubMed ID: 6399429
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum ferritin levels in hematologic malignant neoplasms.
    Patel AR; Shah PC; Vohra RM; Hart WL; Shah JR
    Arch Pathol Lab Med; 1980 Oct; 104(10):509-12. PubMed ID: 6932189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of human serum thymic factor on immature T lymphocytes in acute leukemia and other hematologic malignancies.
    Cavdar AO; Ozger Topuz U; Erten J; Losio M; Erten M; Astaldi G
    Isr J Med Sci; 1978 Dec; 14(12):1216-20. PubMed ID: 107146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beta 2-microglobulin in lymphoproliferative disorders].
    Leoni P; Sprovieri G; Recchioni A; Orrico C; Olivieri A
    G Clin Med; 1983; 64(9-10):315-25. PubMed ID: 6363188
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between tumor proliferation and serum levels of beta 2-microglobulin and thymidine kinase in malignant lymphomas.
    Lehtinen T
    Cancer Detect Prev; 1988; 12(1-6):125-31. PubMed ID: 3052829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.